View in EDS

Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?

Saved in:
Bibliographic Details
Title: Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
Authors: Di Marco L; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Valerio F; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Maculan Y; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Medici B; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Spallanzani A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Dominici M; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Ricci AD; Medical Oncology Unit, National Institute of Gastroenterology, IRCCS 'S. de Bellis' Research Hospital, Castellana Grotte, Italy., Rizzo A; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Salati M; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.
Source: Expert opinion on biological therapy [Expert Opin Biol Ther] 2026 Mar; Vol. 26 (3), pp. 257-267. Date of Electronic Publication: 2026 Mar 11.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41785037
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Di+Marco+L%22">Di Marco L</searchLink>; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Valerio+F%22">Valerio F</searchLink>; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Maculan+Y%22">Maculan Y</searchLink>; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Medici+B%22">Medici B</searchLink>; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Spallanzani+A%22">Spallanzani A</searchLink>; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Dominici+M%22">Dominici M</searchLink>; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Ricci+AD%22">Ricci AD</searchLink>; Medical Oncology Unit, National Institute of Gastroenterology, IRCCS 'S. de Bellis' Research Hospital, Castellana Grotte, Italy.<br /><searchLink fieldCode="AU" term="%22Rizzo+A%22">Rizzo A</searchLink>; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Salati+M%22">Salati M</searchLink>; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101125414%22">Expert opinion on biological therapy</searchLink> [Expert Opin Biol Ther] 2026 Mar; Vol. 26 (3), pp. 257-267. <i>Date of Electronic Publication: </i>2026 Mar 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101125414 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712598%22">14712598 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Biol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41785037
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14712598.2026.2642273
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 257
    Titles:
      – TitleFull: Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Di Marco L
      – PersonEntity:
          Name:
            NameFull: Valerio F
      – PersonEntity:
          Name:
            NameFull: Maculan Y
      – PersonEntity:
          Name:
            NameFull: Medici B
      – PersonEntity:
          Name:
            NameFull: Spallanzani A
      – PersonEntity:
          Name:
            NameFull: Dominici M
      – PersonEntity:
          Name:
            NameFull: Ricci AD
      – PersonEntity:
          Name:
            NameFull: Rizzo A
      – PersonEntity:
          Name:
            NameFull: Salati M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-7682
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Expert opinion on biological therapy
              Type: main
ResultId 1